The method of promoting blood circulation and removing blood stasis in the treatment of intracerebral hemorrhage: A systematic review and meta-analysis protocol of randomized controlled trials

Intracerebral hemorrhage (ICH) is ranked as the second leading cause of death worldwide, it is essential to find appropriate complementary treatment to improve the therapeutic effect of ICH. As a traditional Chinese medicine therapy to unclog blood vessels and restore normal blood flow, many clinical studies have preliminarily proved the effectiveness of the method of promoting blood circulation and removing blood stasis (PBCRBS) in treating ICH. However, this method was once recommended to be prohibited in modern medicine. The purpose of this study was to systematically evaluate the efficacy and safety of PBCRBS in the treatment of ICH and to provide an ideal complementary therapy for ICH. All the randomized controlled trials on treating ICH by PBCRBS from Pubmed and CNKI databases from the establishment of the database to August 2023 will be screened. The subject’s data extraction and the risk of bias assessment will be analyzed. The Cochrane scale, Jadad scale, and GRADE scale will be used to assess the risk of bias, the quality of the studies and results. Revman V.5.4 will be used for meta-analysis and the results will be expressed as relative ratio for binary data and mean difference or standardized mean difference for continuous data. The results of this systematic review and meta-analysis will be published in a peer-reviewed journal. PBCRBS is an effective method for treating ICH.